Pharmacokinetics and bioavailability of pyridinol carbamate in humans. 1979

J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger

The pharmacokinetics of two pyridinol carbamate formulations were studied after a single oral administration in 10 healthy volunteers. An open one-compartment model described the evolution of plasma concentrations as a function of time. Pyridinol carbamate was rapidly absorbed (mean lag time from 0.36 to 0.38 hr). Its elimination half-life ranged from 3.3 to 7.9 hr. The two formulations were bioequivalent.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011727 Pyridinolcarbamate A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408) Pyricarbate,2,6-Pyridinedimethanol-bis-(N-methylcarbamate),Anginin,Angioxine,Colesterinex,Duaxol,Duvaline,Gasparol,Lisator,Movecil,P-23,Parmidine,Prodectin,Sospitan,P 23,P23
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
May 1986, Acta pharmaceutica Hungarica,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
April 1972, Deutsche medizinische Wochenschrift (1946),
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
March 1978, Acta pharmaceutica Hungarica,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
January 1972, La Nouvelle presse medicale,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
October 1984, Journal of pharmaceutical sciences,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
April 1980, Journal of pharmaceutical sciences,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
January 1975, Journal of pharmaceutical sciences,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
November 1986, Arzneimittel-Forschung,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
August 1988, The American journal of medicine,
J Sassard, and N Bernard, and J Legheand, and G Cuisinaud, and J Traeger
January 1979, Materia medica Polona. Polish journal of medicine and pharmacy,
Copied contents to your clipboard!